Related Experiment Video

Updated: Aug 11, 2026

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
10:41

The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli

Published on: January 13, 2013

Streptococcal pharyngitis therapy. A comparison of two erythromycin formulations

C W Derrick, H C Dillon

    American Journal of Diseases of Children (1960)
    |November 1, 1979
    PubMed

    Insights

    Lower doses of erythromycin estolate effectively treat streptococcal pharyngitis in children. This formulation shows superior absorption and tissue levels compared to erythromycin ethylsuccinate, supporting formulation-specific dosing.

    Area of Science:

    • Pediatric infectious diseases
    • Pharmacology and pharmacokinetics
    • Microbiology

    Background:

    • Streptococcal pharyngitis is a common childhood infection requiring effective antibiotic treatment.
    • Current guidelines recommend 30-40 mg/kg/day of erythromycin for children.
    • Previous studies suggested efficacy of lower-dose erythromycin estolate.

    Purpose of the Study:

    • To compare the efficacy of a lower dose of erythromycin estolate with a standard dose of erythromycin ethylsuccinate in treating pediatric streptococcal pharyngitis.
    • To evaluate the impact of formulation on erythromycin efficacy and dosing in children.

    Main Methods:

    • An extension study comparing two treatment groups.
    • Group 1: Erythromycin estolate at 20 mg/kg/day.
    • Group 2: Erythromycin ethylsuccinate at 40 mg/kg/day.

    Main Results:

    • Nearly identical streptococcal eradication rates were observed between the two groups.
    • Erythromycin estolate demonstrated efficacy at a lower dosage than recommended.
    • Pharmacologic factors, including better absorption and higher serum/tissue levels, likely explain the efficacy of erythromycin estolate.

    Conclusions:

    • Erythromycin estolate is effective at 20 mg/kg/day for pediatric streptococcal pharyngitis.
    • Dosage calculations for erythromycin should consider the specific formulation administered.
    • Formulation-specific pharmacokinetics influence treatment efficacy in children.

    More Related Videos

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation05:46

    Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation

    Published on: August 1, 2018

    Related Concept Videos

    Acute Pharyngitis01:30

    Acute Pharyngitis

    Introduction
    Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
    Classification
    Acute pharyngitis can be categorized based on its underlying cause:
    Tonsillitis II: Management01:26

    Tonsillitis II: Management

    This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

    Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

    Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
    Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

    Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

    Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
    Streptococcal Pharyngitis01:27

    Streptococcal Pharyngitis

    Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
    Inhibitors of Bacterial Protein Synthesis01:25

    Inhibitors of Bacterial Protein Synthesis

    Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...